Heterocyclic derivatives and their use in the treatment of neurological disorders
申请人:NOVARTIS AG
公开号:US10035794B2
公开(公告)日:2018-07-31
The invention relates to novel heterocyclic compounds of the formula
in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, combinations thereof, and their use as medicaments, particularly for the treatment of Alzheimer's Disease or diabetes via inhibition of BACE-1 or BACE-2.
本发明涉及式如下的新型杂环化合物
其中所有变量均如说明书中所定义、其药物组合物、其组合物及其作为药物的用途,特别是通过抑制 BACE-1 或 BACE-2 治疗阿尔茨海默氏症或糖尿病。